Leap Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
Cypherpunk Technologies Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 18, 2026, to elect directors, vote on executive compensation, and ratify auditor appointments.
Cypherpunk Technologies Inc. reminds shareholders of a special meeting on December 15, 2025, to vote on proposals including increasing authorized shares, a reverse stock split, an equity incentive plan, and a private placement issuance.
Leap Therapeutics rebrands as Cypherpunk Technologies, adopts a Zcash treasury strategy, and appoints Khing Oei as Chairman and William McEvoy as CIO.
Leap Therapeutics, Inc. is seeking stockholder approval for proposals including an increase in authorized shares, a reverse stock split, a new equity incentive plan, and the potential issuance of over 19.99% of common stock upon warrant exercise.
Leap Therapeutics calls a special meeting to approve a significant share increase, a potential reverse stock split for Nasdaq compliance, and a new equity plan, following a $58.88 million private placement led by Winklevoss Capital.
Leap Therapeutics will hold its annual shareholder meeting virtually on June 18, 2025, to vote on director elections, executive compensation, and auditor ratification.
Leap Therapeutics will hold its 2025 Annual Meeting of Stockholders virtually on June 18, 2025, to elect directors, approve executive compensation, and ratify the appointment of its independent auditors.
Leap Therapeutics issues a supplement to its proxy statement to correct an administrative error on the proxy card related to the election of directors.
Leap Therapeutics will hold its annual shareholder meeting virtually on July 2, 2024, to vote on director elections, executive compensation, an equity incentive plan amendment, and auditor ratification.
Leap Therapeutics announces its 2024 Annual Meeting of Stockholders to be held virtually on July 2, 2024, featuring proposals for director elections, executive compensation, equity incentive plan amendments, and auditor ratification.